.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Equity Extracts is stocked at 38 licensed dispensaries across Maryland, with the deepest coverage in Annapolis, Baltimore, Hagerstown, Pasadena, and Silver Spring. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Equity Extracts concentrated 70.55% of sales in Vapor Pens and 29.45% in Concentrates, while overall brand sales were down 57.37% year over year and the average price fell 13.03%. Within the mix, Vapor Pens declined 38.41% YoY and 5.31% MoM at an average price of $26.49, whereas Concentrates contracted 75.46% YoY and 40.27% MoM at an average price of $22.06. With Vapor Pens carrying a 41st rank in Maryland and holding more than double the share of Concentrates, the pattern implies the brand’s near-term volume is anchored to Vapor Pens despite broad contraction across both categories.
The sharper 40.27% MoM drop in Concentrates versus a 5.31% MoM decline in Vapor Pens, coupled with a 75.46% YoY fall in Concentrates against 38.41% in Vapor Pens, implies an intentional or forced retrenchment toward the higher-share Vapor Pens line to stabilize throughput. Given a 13.03% YoY decrease in average price alongside a category mix that tilts 70.55% to Vapor Pens, the data suggests Equity Extracts is prioritizing price-accessible SKUs in Vapor Pens to defend baseline share while de-emphasizing Concentrates where elasticity or distribution pressure is steeper; this positioning points to a volume-first approach that trades margin for rank protection in Maryland.
Competitive Landscape
Equity Extracts sits at rank #41 in MD Vapor Pens in October 2026, down 5 spots year over year from #36 and 4 spots from July 2026’s #37, while still far off its peak at #21 in March 2025; in contrast, Select held #1 with a 17.4% YoY sales increase and Hellavated moved up from #3 to #2 with 12.8% YoY growth, indicating that Equity Extracts is losing rank share to leaders who are either maintaining or improving their positions. The combination of a 5-rank YoY decline and a 4-rank slide over the last three months, alongside competitors like Rove climbing to #5 from #7 with 53.2% YoY growth, implies the brand’s trajectory is flattening into the lower tier unless assortment or pricing shifts re-engage velocity.
Notable Products
Equity Extracts leans on format concentration in October 2026, with Vapor Pens Cartridges accounting for 66.9% of sales and Shatter at 29.5%. The top product, Amnesia BDT Distillate Cartridge (1g), holds 13.0% on its own, so most of its sales come from cartridges with shatter as the secondary driver.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
